Successful treatment of an elderly patient with lung squamous cell carcinoma by tislelizumab and chemotherapy: a case report with novel imaging findings

Successful treatment of an elderly patient with lung squamous cell carcinoma by tislelizumab and chemotherapy: a case report with novel imaging findings

The advent of immunotherapy has transformed the therapeutic landscape for inoperable, locally advanced Non-Small cell lung cancer (NSCLC), particularly for lung squamous cell carcinoma (LUSC) with a predominance of negative driver genes. Based on the results of clinical trials such as KEYNOTE-042 an...

Full description

Saved in:
Bibliographic Details
Main Authors: Lufan Xu, Xinxin Ma, Yang Yang, Zhiqiang Ding, Yi Luo
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-03-01
Series:Frontiers in Immunology
Subjects:
lung squamous cell carcinoma
tislelizumab
PD-1 inhibitor
immunotherapy
chemotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1543114/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items